Socialiya - Entertainment. Knowledge. Community.
Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, accord...

HEALTH NEWS June 01, 2026

Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial.

2 views 0 likes 0 comments
Share:
An experimental drug nearly doubled the overall survival rates of pancreatic cancer patients, according to the results of its latest clinical trial.

Author: USA Today

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya